l. Each party shall have received an accurate translation of each of the foregoing documents that has not been drafted in its native language, and such translation shall be an accurate reflection of the agreement of the parties. In addition, the...Master Joint Venture Agreement • December 6th, 1996 • Thermolase Corp • Perfumes, cosmetics & other toilet preparations • Delaware
AMENDED AND RESTATED MASTER JOINT VENTURE AGREEMENT By and Among EVERGREEN SOLAR, INC. Q — CELLS SE RENEWABLE ENERGY CORPORATION ASA and EVERQ GmbH (envisaged SOVELLO AG)Master Joint Venture Agreement • March 2nd, 2009 • Evergreen Solar Inc • Semiconductors & related devices
This Amended and Restated Master Joint Venture Agreement (the “Agreement”) is made and entered into on November 5, 2008, by and between
BY AND AMONGMaster Joint Venture Agreement • March 16th, 2006 • Evergreen Solar Inc • Semiconductors & related devices
Master Joint Venture AgreementMaster Joint Venture Agreement • June 27th, 2008 • Bank of Chile • Commercial banks, nec • New York
ANNEX “1” of the Master Joint Venture Agreement dated October 19, 2020Master Joint Venture Agreement • January 7th, 2022 • Instadose Pharma Corp. • Household furniture
EX-2.1 2 dex21.htm MASTER JOINT VENTURE AGREEMENT MASTER JOINT VENTURE AGREEMENT by and between Maxygen, Inc., a Delaware Corporation, Astellas Phama Inc., a Japanese Corporation, and Astellas Bio Inc., a Delaware Corporation Dated as of June 30, 2009...Master Joint Venture Agreement • May 5th, 2020 • Delaware
This Master Joint Venture Agreement (this “Agreement”) is made and entered into as of this 30th day of June, 2009 by and between Maxygen, Inc. a Delaware corporation, having its principal offices at 515 Galveston Drive Redwood City, CA 94063 (together with its Affiliates, “Maxygen”), Astellas Pharma Inc., a Japanese corporation, having its principal offices at 2-3-11, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan (“Astellas”) and Astellas Bio Inc., a Delaware corporation, having its principal offices at Three Parkway North Deerfield, IL 60015-2548 (“Bio”). Maxygen, Astellas and Bio are together referred to herein as the “Parties.”
AMENDMENT TO THE MASTER JOINT VENTURE AGREEMENTMaster Joint Venture Agreement • June 29th, 2009 • Bank of Chile • Commercial banks, nec
Amendment of the Master Joint Venture AgreementMaster Joint Venture Agreement • October 29th, 2007 • Evergreen Solar Inc • Semiconductors & related devices
Q-Cells AG, registered in the companies’ register of the local court of Stendal under HRB 16621, Guardianstrasse 16, 06766 Thalheim, Germany (hereinafter “Q-Cells”), Evergreen Solar, Inc., registered in the register of the State of Delaware (USA) under no.: 2426798, 138 Bartlett Street, Marlboro, Massachusetts 01752, USA) hereinafter “Evergreen”), Renewable Energy Corporation ASA, registered in the Bronnoysundregisterene (norwegian companies’ register) under the organisational number 97725861, Veritasveien 14, 1323 Hovik, Norway (hereinafter “REC”, and Q-Cells, Evergreen and REC are hereinafter referred to as “the Shareholders” as well as altogether “the Parties”.), and EverQ GmbH, registered in the companies’ register of the local court of Stendal under HRB 4769, Sonnenallee 14-24, 06766 Bitterfeld-Wolfen, Germany, (hereinafter “EverQ”) entered into this Amendment to the Master Joint Venture Agreement on October 23, 2007.
